Search results: “PD-L2”

Accelerate cancer immunotherapy drug development with easy-to-use, functional cell-based assays targeted at checkpoint receptors

Simple, non-radioactive, & dye-free cytotoxicity assays to specifically measure target cell death

Accelerate cancer immunotherapeutic discovery & development with cell-based, clinically relevant assays